Loading…
Omeros is a biopharmaceutical company focused on developing next-generation therapeutics to transform patient care across a range of diseases. The company targets both ultra-orphan and large-market indications with a data-driven approach to create life-saving therapies and improve patient outcomes.
AI named Omeros in October 2025.